KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Shares Outstanding (Weighted Average) (2016 - 2026)

Globus Medical filings provide 15 years of Shares Outstanding (Weighted Average) readings, the most recent being $135.2 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) changed 0.38% to $135.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $135.2 million, a 0.38% change, with the full-year FY2025 number at $135.2 million, changed 0.38% from a year prior.
  • Shares Outstanding (Weighted Average) hit $135.2 million in Q4 2025 for Globus Medical, roughly flat from $135.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $136.8 million in Q1 2025 to a low of $99.9 million in Q1 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $107.3 million (2022), compared with a mean of $115.9 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): dropped 1.3% in 2023 and later soared 34.98% in 2024.
  • Globus Medical's Shares Outstanding (Weighted Average) stood at $100.7 million in 2021, then dropped by 0.26% to $100.5 million in 2022, then grew by 12.56% to $113.1 million in 2023, then increased by 20.02% to $135.7 million in 2024, then fell by 0.38% to $135.2 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $135.2 million (Q4 2025), $135.5 million (Q3 2025), and $136.0 million (Q2 2025) per Business Quant data.